RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. ARTIS Ventures
A

ARTIS Ventures portfolio

ARTIS Ventures has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Website: av.co.
Type: Venture capital.
Portfolio on Recent Funding: 6.
Deals, last 12 months: 1.
Rounds led: 2 of 6.
Capital in their rounds: $276M.
Latest deal: Unnatural Products · Mar 16, 2026.
About this page

It is a venture capital firm based in San Francisco, US, founded in 2022. It led 2 of the 6 rounds it joined. Its most recent investment on record is Unnatural Products's $45M Series B+ round in March 2026, alongside Merck Global Health Innovation Fund, argenx, Droia Ventures and 2 others. By category, its portfolio leans toward Health and bio (5) and Legal and compliance (1). It has co-invested with The Venture Collective, Merck Global Health Innovation Fund and First Spark Ventures, most often The Venture Collective (2 rounds).

About ARTIS Ventures

Firm type: Venture capital.
Headquarters: San Francisco, US.
Founded: 2022.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: AI & Machine Learning, Biotech, Consumer, Deep Tech, Digital Health, Fintech, Healthtech, Medical Devices.
Check size: $50K to $25M.
Leads rounds: Yes.
Portfolio companies: 120.
Exits: 2.
Rounds led: 2.

Funds raised

FundFund #SizeAnnounced
AARTIS Ventures
SF, NYC
IV$200M
HIT Consultant

What ARTIS Ventures invests in

ARTIS Ventures recent investments

CompanyRoundDateAlongside
UUnnatural ProductsSeries B+ · $45MMerck Global Health Innovation Fund, argenx, Droia Ventures +2
CCartography BiosciencesSeries B+ · $67MGlobal BioAccess Fund, Wing VC, Gaingels +6
VValarianSeed · leadMD ONE Ventures, IQ Capital, Molten Ventures +2
UUnnatural ProductsSeries A · $32M · leadMerck Global Health Innovation Fund (lead), First Spark Ventures, The Venture Collective (lead) +4
CCartography BiosciencesSeries A · $57MWing VC, Gaingels, 8VC (lead) +5
OONISeries B+ · $75MCasdin Capital (lead), ARCH Venture Partners (lead), Vertical Venture Partners +3

How ARTIS Ventures invests

StageDealsCapital in rounds
Series B+ 3 50%$187M
Series A 2 33%$89M
Seed 1 17%undisclosed
YearDealsCapital in rounds
2022 2 33%$132M
2023 1 17%$32M
2025 2 33%$67M
2026 1 17%$45M

ARTIS Ventures portfolio companies

CompanyRound with ARTIS VenturesTotal raisedLatest raise
UUnnatural Products
Health and bio
 Series B+ · $45M$77MMar 16, 2026
Series B+
CCartography Biosciences
Health and bio
 Series B+ · $67M$124MOct 2, 2025
Series B+
VValarian
Legal and compliance
 Seed · lead$50MJul 14, 2026
Series A
OONI
Health and bio
 Series B+ · $75M$75MJan 29, 2022
Series B+
GGenHealth.ai
Health and bio
 backer$16.5MOct 8, 2026
Series A
OOverT Bio
Health and bio
 backer$16MMay 6, 2024
Seed

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds ARTIS Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 6 rounds on Recent Funding that name ARTIS Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists ARTIS Ventures, which is a subset of its real portfolio. API: /api/v1/investors/artis-ventures (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy